Recent federal awards
Most recently updated awards associated with this UEI.
POMALYST 2 MG, 3 MG,4 MGDepartment of Veterans Affairs$199.0KEnds Aug 31, 2026
MAVACAMTEN (CAMZYOS) AND POMALIDOMIDE (POLMALYST)Department of Veterans Affairs$300.0KEnds Sep 30, 2026
POMALYST 4MG, CAMZYOS 2.5 MGDepartment of Veterans Affairs$51.3KEnds Sep 30, 2026
MAVACAMTEN (CAMZYOS) AND POMALIDOMIDE (POLMALYST)Department of Veterans Affairs$365.1KEnds Sep 30, 2026
EMERGENCY BREYANZIDepartment of Veterans Affairs$364.1KEnds Sep 30, 2026
POMALYST 3 MGDepartment of Veterans Affairs$10.9KEnds Aug 4, 2026
MAVACAMTEN (CAMZYOS) 5 MG AND POMALIDOMIDE (POMALYST) 2 MGDepartment of Veterans Affairs$232.8KEnds Sep 30, 2026
POMALIDOMIDE(POMALYST) 4MG CAPDepartment of Veterans Affairs$16.4KEnds Jul 21, 2026
POMALYST 2 MG, 3 MG,4 MGDepartment of Veterans Affairs$138.3KEnds Jul 24, 2026
POMALYST 3 MGDepartment of Veterans Affairs$10.9KEnds Jul 10, 2026
Expiring contracts
Public awards with modeled positioning windows.
BREYANZI CAR-TDepartment of Veterans Affairs$364.1KEnds Sep 25, 202665% recompete estimate
POMALYST 2 MG, 3 MG,4 MGDepartment of Veterans Affairs$199.0KEnds Aug 31, 202665% recompete estimate
BREYANZI CAR T - TRANSPLANTDepartment of Veterans Affairs$364.1KEnds Sep 17, 202665% recompete estimate
POMALYST 4MG, CAMZYOS 2.5 MGDepartment of Veterans Affairs$51.3KEnds Sep 30, 202665% recompete estimate
EMERGENCY BREYANZIDepartment of Veterans Affairs$364.1KEnds Sep 30, 202670% recompete estimate
MAVACAMTEN (CAMZYOS) AND POMALIDOMIDE (POLMALYST)Department of Veterans Affairs$300.0KEnds Sep 30, 202665% recompete estimate
BREYANZI CAT-T TRANSPLANTDepartment of Veterans Affairs$364.1KEnds Sep 1, 202665% recompete estimate
BREYANZI CAR T-TRANSPLANTDepartment of Veterans Affairs$364.1KEnds Aug 31, 202665% recompete estimate
BREYANZI CAR TDepartment of Veterans Affairs$364.1KEnds Sep 17, 202665% recompete estimate
MAVACAMTEN IS AN OUTPATIENT DRUG USED IN THE TREATMENT OF SPECIFIC TYPES OF CARDIOMYOPATHIES.Department of Veterans Affairs$327.5KEnds Sep 30, 202665% recompete estimate
Recompete percentages and windows are AcornBids estimates, not agency forecasts or guarantees.